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Inflammasomes are intracellular protein complexes of pattern recognition receptors
and caspase-1, with essential functions in regulating inflammatory responses of
macrophages and dendritic cells. The primary role of inflammasomes is to catalyze
processing and secretion of pro-inflammatory cytokines IL-1β and IL-18. Recently,
intracellular non-canonical inflammasome activation by caspases-4/5, which are also
regulators of pyroptosis via processing gasdermin D, has been elucidated. Caspase-1,
the effector protease of inflammasome complex, is also known to modulate secretion
of large number of other proteins. Thereby, besides its known role in processing
pro-inflammatory cytokines, the inflammasome turns into a universal regulator of protein
secretion, which allows the danger-exposed cells to release various proteins in order
to alert and guide neighboring cells. Majority of these proteins are not secreted
through the conventional ER-Golgi secretory pathway. Instead, they are segregated
in membrane-enclosed compartment and secreted in nanosized extracellular vesicles,
which protect their cargo and guide it for delivery. Growing evidence indicates that
inflammasome activity correlates with enhanced secretion of extracellular vesicles
and modulation of their protein cargo. This inflammasome-driven unconventional,
vesicle-mediated secretion of multitude of immunoregulatory proteins may constitute a
novel paradigm in inflammatory responses. In this mini review we discuss the current
knowledge and highlight unsolved questions about metabolic processes, signals, and
mechanisms linking inflammasome activity with regulated extracellular vesicle secretion
of proteins. Further investigations on this relationshipmay in the future help understanding
the significance of extracellular vesicle secretion in inflammatory diseases such as
atherosclerosis, gouty arthritis, asthma, Alzheimer’s and many others.
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INTRODUCTION
Extracellular vesicles (EV) are a heterogeneous group of
membrane-enclosed carriers of biomolecules, secreted by all
mammalian cells. This umbrella term refers to the pool of all
vesicles, ranging in size from 30 to over 1,000 nm, constituting
of exosomes (derived from endosomal compartment), ectosomes
(microvesicles budding from plasma membrane) and apoptotic
bodies [fragments of apoptotic cells, (1)]. Secretion of EV by
immune cells constitutes a conserved mechanism of release
of biomolecules (notably proteins, bioactive lipids and nucleic
acids) both as a “waste disposal” and for targeted intercellular
signaling. The latter became a major focus of immunologists’
research efforts in the past decade. In innate immunity, secretion
of EV by leukocytes is a tightly regulated process, dependent on
the activation state of the cells (2). During immune response,
EV are selectively loaded with immune regulatory proteins, like
cytokines, what makes them important messengers delivering
targeted biological signals. The vesicular signaling now emerges
as a critical component of innate immunity that orchestrates
actions of multiple immune system cells in infectious and
inflammatory diseases.
Inflammasomes are molecular structures of the innate
immune system that are critical for both local and systemic
inflammation. Among them canonical NOD-like receptor
protein 3 (NLRP3) is the most studied and known to sense
multiple microbial and endogenous danger signals. NLRP3
activation results in caspase-1-dependent processing and
secretion of critical pro-inflammatory cytokines interleukin
(IL)-1β and IL-18, as well as drives pro-inflammatory cell
death (pyroptosis). More recently non-canonical, caspase-
4/5-dependent inflammasome has been described. These
novel caspases binding to intracellular LPS, directly regulate
pyroptosis, and activate canonical NLRP3-mediated IL-1β and
IL-18 processing. Caspases-4/5 are critical for development of
endotoxic shock in mice (3).
EV secretion has long been linked with inflammation
and various experimental models were applied to characterize
the roles the EV play in the development and progression
of inflammatory diseases. In particular, EV isolated from
patient body fluids have been studied in search for disease
biomarkers and early diagnosis possibilities of such inflammatory
diseases as atherosclerosis (4–6), Alzheimer’s disease (7–10),
and rheumatoid arthritis (11). EV secreted during inflammatory
response are thought to promote inflammation in endothelial
cells, neutrophils, hepatocytes, macrophages, and monocytes
via various mechanisms: delivery of inflammasome components
and cytokines, activation of surface receptors, induction of
expression of inflammatory mediators and others [reviewed
recently in (12)].
Contrary to extensive documentation on biological functions
of EV in inflammatory diseases, mechanistic explanations of
how the inflammasome activity regulates secretion of EV and
modulates their cargo and biological properties in inflammatory
cells are vague. Use of high-throughput proteomic approaches
has contributed substantially to our knowledge in these aspects
and allowed to elucidate novel signals for EV secretion
in inflammatory response. Using proteomics, we and others
showed that canonical NLRP3 activators (calcium oxalate and
monosodium urate (MSU) crystals, ATP, β-glucans, viral RNA)
as well as non-canonical, caspase-4-dependent activation, induce
secretion of EV and EV-associated proteins (13–18). In this
mini review we discuss the current knowledge and highlight
unsolved questions about signals, processes and mechanisms
linking NLRP3 inflammasome activity with regulated EV-
mediated secretion of pro-inflammatory cytokines and other
immunoregulatory proteins.
MULTIPLE CANONICAL NLRP3
ACTIVATORS INDUCE EV SECRETION
ATP
Extracellular ATP is an endogenous danger signal known to
activate inflammatory response in innate immune cells including
macrophages. The receptor for ATP is P2X purinoceptor 7
(P2X7), which is a transmembrane ATP-gated ion channel
(19). Ligation of P2X7 results in strong activation of NLRP3
inflammasome (20). We have shown that ATP-induced NLRP3
inflammasome activation is followed by robust activation of
EV-mediated protein secretion, including exosome release
and membrane shedding in human macrophages (15).
Interestingly, de Torre-Minguela et al. showed that P2X7-
induced protein secretion does not depend on de novo protein
synthesis (21). This observation suggests that activation
of P2X7 ion channel causes rapid, probably non-specific
sequestration of proteins at the vicinity of the plasma
membrane and their release in shedding microvesicles. It is
currently not clear if this process is inflammasome-dependent,
as secretion of only part of the proteins was shown to be
affected by caspase-1. Moreover, the study revealed multiple
proteins whose secretion was caspase-1-dependent in M1
pro-inflammatory macrophages, but not M2, suggesting
existence of more sophisticated, cell-specific regulatory
mechanisms (21).
Monosodium Urate and β-Glucans
Monosodium urate (MSU) and β-glucans are crystalline agents
that activate NLRP3 inflammasome. MSU crystals have emerged
as a causative factor for gouty arthritis through NLRP3 activation
and following IL-1β secretion (22). β-glucans are the main
components of fungal cell walls and they activate robust innate
immune reaction. We have shown that both MSU crystals
and β-glucans activate strong EV-mediated protein secretion
in human macrophages (13, 14, 23). This protein secretion
was dependent on the activity of Syk kinase and lysosomal
proteases cathepsins, as well as caspase-1. This indicates that Syk
kinase activity and lysosome damage, which both are involved
in NLRP3 inflammasome activation (24), provide also a signal
for the induction of EV secretion upon recognition of crystalline
substances damaging lysosomes. These results also suggested
that NLRP3 activity is required for MSU- and β-glucan-induced
EV-mediated protein secretion.
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Nigericin
Nigericin is a microbial toxin derived from Streptomyces
hygroscopicus, which has the ability to induce P2X7-independent
potassium efflux and following activation of the NLRP3
inflammasome. Zhang and colleagues studied the effect of LPS
and nigericin on EV secretion in mouse bone marrow-derived
macrophages. LPS alone was not sufficient to induce substantial
EV protein secretion as compared with LPS priming followed by
nigericin stimulation (25). Thus, EV secretion may constitute a
secondary effect of NLRP3 activity. Of note, proteomic analysis
identified IL-1β andNLRP3 in the EV from LPS/nigericin-treated
cells (25), adding EV-mediated secretory route to previous
observations of secretion of inflammasome components during
inflammatory response (22). Functionally, these EV were able to
induce NF-κB signaling in recipient cells, suggesting that EV-
mediated transport of proteins (and possibly other biomolecules)





The discovery that human caspases-4/5 (caspase-11 in mice)
are novel pattern recognition receptors which directly recognize
intracellular LPS fundamentally changed the understanding of
inflammasome responses (3, 26–33). It was shown that caspases-
4/5 activate NLRP3 inflammasome and processing of IL-1β
and IL-18. Non-canonical caspases-4/5 also mediate cleavage
of gasdermin D, yielding an N-terminal polypeptide which
inserts into the cellular membrane and oligomerizes, forming
a pore and inducing subsequent pyroptosis independently of
NLRP3 (33, 34). Very recent data shows that gasdermin D also
has a pyroptosis-independent function in phagocytic cells: it
mediates IL-1β secretion in living macrophages which undergo
“hyperactivation” in response to bacteria and oxidized lipids
(35). It was speculated that pyroptosis-independent IL-1β release
may be a result of weak or modest activation of NLRP3
inflammasome, contrary to strong activation which triggers
pyroptotic death (36).
Currently very limited data concerning EV secretion
associated with non-canonical inflammasome response is
available. In our recent study, we utilized label-free quantitative
proteomics to characterize global protein secretion in response
to non-canonical caspase-4/5 inflammasome activation in
human macrophages (17). We demonstrated that non-canonical
caspase-4/5 inflammasome activates robust EV-mediated protein
secretion in human macrophages. Caspase-4 inhibitor blocked
both IL-18 and EV secretion in macrophages in response to
intracellular LPS treatment (17). However, it was not studied
if NLRP3 inflammasome (which is also activated downstream
of non-canonical caspases) is involved in the activation of EV-
mediated protein secretion following intracellular LPS delivery.
The role of gasdermin D in generation and secretion of EV is
likewise unknown.
THE ROLE OF EV IN NLRP3-MEDIATED
IL-1β RELEASE
Neither the 31kDa precursor nor mature 17 kDa form of IL-
1β carry an N-terminal signal sequence. Upon processing by
the inflammasome, mature IL-1β is targeted for release via
poorly understood secretory route. Numerous mechanisms have
been proposed to mediate IL-1β release, including homeostatic
processes, like secretory autophagy (37–40) and lysosome
exocytosis (41), as well as radical processes, resulting in cell death:
pyroptosis (31) and necrosis (42). It has been suggested that
rather than being secreted by one tightly controlled mechanism,
the cytokine is exported in multiple ways simultaneously (43).
Recent discoveries demonstrated that IL-1β secretion proceeds
through gasdermin D membrane pores (31, 33, 35, 44), however
it is still unclear how mature cytokine is exported through
the pore. It seems that gasdermin D pore-mediated release
is a primary secretory route for mature IL-1β secretion at
initial stages of inflammatory response, as Gsdmd−/− mouse
macrophages secrete drastically reduced amounts of the cytokine
upon canonical and non-canonical inflammasome stimulations
(45). However, as gasdermin D-deficient mutants are resistant to
pyroptosis but not apoptosis, it seems plausible that additional
death-related mechanisms are involved in IL-1β secretion. For
example, one study argued that secretion of mature IL-1β is a
result of necrotic cell death, as THP1 macrophages that survived
nigericin treatment retained the cytokine, contrary to dying cells
(42). For more detailed perspectives on IL-1β processing and
secretion the reader is referred to recent detailed reviews (40, 46).
Secretion of EV constitutes also an important auxiliary mean
of IL-1β export. Both pro-form and mature IL-1β and IL-18 have
been also observed in shedding microvesicles released from cells
upon NLRP3 activation through distinct pathways (14, 47–49). It
has been suggested that sequestration of activated inflammasome
complex together with IL-1β and IL-18 precursors and their
secretion on EV may precede the inflammasome activation
within the lumen of the vesicle, thereby proposing an attractive
explanation for observing both immature and mature cytokine
forms present in EV (50). However, despite these and a small
number of other studies identifying the presence of IL-1β in
association with vesicles, the EV have not been fully elucidated
as a secretory mechanism of IL-1β and IL-18.
MECHANISTIC LINKS BETWEEN NLRP3
ACTIVITY AND EV SECRETION
Transmembrane Calcium/Potassium
Fluxes
Changing transmembrane ionic balance of calcium and
potassium is a critical signal for canonical NLRP3 activation
(51–53). Potassium efflux and concomitant calcium influx is
triggered by ionophores [streptolysin O (54), nigericin (55),
maitotoxin (20)], as well as activators of P2X7 receptor (56),
which are known for their rapid inflammasome activation.
NLRP3 inflammasome is also activated by intracellular release of
calcium from lysosomal compartment (55, 57).
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Calcium influx is also a promoter of EV secretion (58).
Calcium influx activates calcium-dependent floppase and
scramblase, which are involved in exposing phosphatidylserine
and phosphatidyethanolamine on the outer plasma membrane
sheet, causing outward budding of the membrane. Subsequent
reorganization of the cytoskeleton facilitates pinching off of the
forming microvesicle (59).
Calcium (Ca2+) ions are important for cellular signaling,
as once they enter the cytosol of the cytoplasm they regulate
the activity of many enzymes and proteins. Calpains are
cytosolic calcium-sensitive enzymes, involved in processing
of many cytoskeletal proteins. They are also important
for secretion of EV (60, 61). Crespin et al., showed that
inhibition of calpains reduces microvesicle shedding resulting
from calcium ionophore treatment in platelets (62). In our
study we further explored the ATP-mediated inflammasome
activation and EV secretion, showing that activation of
calpains may be the missing link between P2X7-mediated ionic
fluxes and inflammasome activation. In human macrophages,
calpain inhibition supresses inflammasome activation and
IL-1β secretion upon ATP and β-glucan treatment, but
surprisingly not nigericin, a P2X7-independent potassium
ionophore. It also completely abrogates ATP-induced EV
secretion (15). This suggests that in macrophage P2X7-
NLRP3 axis, calpain activation by calcium influx is required
for both inflammasome activity and EV secretion, while
for P2X7-independent ionophores calpain function may be
dispensable.
Lysosomal Damage
Lysosome destabilization occurring during phagocytosis and
endocytosis of crystalline particles is another well-established
trigger of NLRP3 activation. These stimuli include cholesterol
crystals (63, 64), MSU (22), calcium phosphate (65), and
particulate β-glucans (66). During lysosomal membrane
destabilization two major events have been demonstrated to
play major role in triggering inflammasome assembly: leakage of
lysosomal cathepsins, and potassium efflux.
Interestingly, we have also demonstrated that cathepsins play
role in secretion of EV-associated proteins in the course of
TLR3-mediated double-stranded RNA recognition in human
macrophages in a model of viral infection (67). However whether
EV secretion is modulated by cathepsin inhibition was not
directly addressed. More recently, another group evaluated
the roles of cathepsins in inflammasome activation, showing
that neither widely used cathepsin inhibitor Ca-074-Me, nor
alternative K777, are specific antagonists of a single cathepsin
(68). Therefore the link between lysosome damage-induced
NLRP3 activation and EV secretion is rather a combined
effect of different cathepsins activity, whose roles need further
elucidation. This also remains to be confirmed e.g., by using
selective NLRP3 inhibitors. Concomitantly, the involvement of
Syk and lysosomal cathepsins in activation of EV secretion needs
also to be verified for other particulate NLRP3 activators like
alum, asbestos or silica.
FIGURE 1 | Proposed relationship between NLRP3 inflammasome and
vesicular protein secretion. (A) Signal 1, provided by IL1R, TLRs, and other
PRRs induces the transcription and expression of NLRP3, as well as precursor
forms of inflammatory cytokines IL-1β and IL-18. It also leads to induction of
expression of hundreds of other proteins. (B) Signal 2 activates inflammasome
which catalyzes processing of pro-IL-1β and gasdermin D. N-terminal
fragment of gasdermin D inserts into cell membrane and oligomerizes, forming
a pore, which allows for direct secretion of small proteins, cytokines, and
enhances ionic fluxes across the membrane. Additionally, calcium and
potassium concentrations are also affected by membrane antiporter receptors
(e.g., P2X7) or lysosomal leakage, amplifying inflammasome activation and
causing activation of floppases, flippases, and scramblases, which catalyze
transbilayer translocation of phosphatidylserine and phosphatidylethanolamine.
(C) This affects membrane curvature, causing outward budding and formation
of microvesicles, and incorporation of proteins in the vicinity of the membrane
(including pro-IL-1β and mature IL-1β) as well as integral membrane proteins in
(Continued)
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FIGURE 1 | their lumen. Rapid processing of IL-1β may also result in
recruitment of mature IL-1β into intraluminal vesicles of multivesicular body
(MVB), a component of endosomal pathway, which traffics its content directly
to the membrane, releasing exosomes. (D) Prolonged inflammasome activity
leads to pyroptosis which may involve release of inflammasome components,
cytokines, and other proteins via membrane lysis or larger vesicular structures
resulting from cell fragmentation.
Caspase-1 Activity
Caspase-1, beyond its well-documented pro-IL-1β and pro-IL-
18-processing functions, is also involved in secretion of other
leaderless proteins. Keller and colleagues demonstrated that UVB
irradiation-activated keratinocytes secrete over 900 proteins, of
which secretion of 77 was significantly modulated in the presence
of caspase-1 inhibitor YVAD (69). Interestingly, only a small
number of these proteins are known to be direct caspase-1 targets
(70). Many of them are also known to be secreted via EV. This
revealed that caspase-1 may be directly involved in control of EV
secretion and loading (70).
Moreover, upon discovering that inflammasome complexes
can be secreted in EV, it has been proposed that caspase-
1 activation is critical for sequestration of ASC specks and
other inflammasome components in vesicular compartment for
secretion and delivery to neighboring cells. Uptake of such
“inflammasome-EV” is perceived as a mean of local propagation
of inflammatory response (71, 72).
In contrast, a study published by Qu et al. argued against
the critical role of caspase-1 in P2X7-mediated activation of
EV secretion. The authors suggested that exosome secretion
is a consequence of NLRP3 and ASC activity, while caspase-1
was dispensable (73). However, this study was performed on
murine bone marrow-derived macrophages and dendritic cells
and the EV secretion was mainly assessed by immunoblotting of
MHCII, which is not a classical exosomal/EV marker, with lack
of other validation methods. Corroborating this data, our study
also indicated that caspase-1 inhibition by Z-YVAD-FMK was
insufficient to prevent EV-mediated protein secretion induced by
ATP in human macrophages (15).
CONCLUSIONS AND PERSPECTIVES
Secretion of EV is currently perceived as a fundamental mode
of intercellular communication, having impact on cell-to-cell
delivery of proteins, lipids and nucleic acids. Circulating EV
form a signaling network of the immune system, where various
cells in blood and tissues exchange EV which coordinate
homeostasis and alert the immune system upon sensing the
danger. Growing number of studies now support the view that
human phagocytic cells modulate secretion kinetics and cargo
of EV during inflammatory response. There is strong evidence
that EV secretion correlates with inflammasome activity (2,
13–18, 23, 25) and that the “inflammasome-induced” EV can
activate inflammatory responses in recipient cells (25). Therefore
activation of EV secretion via different mechanisms is possibly
a universal outcome of inflammasome activity with evolutionary
determined immune signaling.
Based on the available data, we postulate a model of
inflammasome-dependent EV secretion as a sequential
process, which serves the release of pro-inflammatory
cytokines, as well as numerous other proteins whose
relationship to inflammasome remains to be determined
(Figure 1). Signal 1, delivered by surface PRRs during priming
induces expression of inflammasome components and pro-
inflammatory cytokines, but activates no inflammasome
assembly or significant EV secretion [(25), Figure 1A]. Upon
signal 2, assembly of the inflammasome with caspase-1
activation triggers processing of pro-inflammatory cytokines
and gasdermin D. Active gasdermin D translocates to the
membrane forming pores for cytokine secretion, but also
further affecting transmembrane calcium/potassium equilibrium
(Figure 1B). Cationic fluxes amplify signal 2 and simultaneously
affect two parallel processes that facilitate formation and
secretion of EV: (a) activating inflammatory caspases (possibly
including non-canonical caspases 4 and 5) that are directly
or indirectly involved in processing cytoskeletal proteins,
compromising membrane rigidity and microvesicle formation,
(b) modulating reorganization of plasma membrane sheets, with
phosphatidylserine exposure as a result of calcium-activated
phospholipid transporters. The forming shedding compartment
carries the local cargo proteins, including processed and
unprocessed cytokines, or even entire inflammasome complexes.
Mature cytokines may also be targeted to multivesicular bodies
(MVB) and secreted in exosomes. Thus at this stage, formation
of EV via multiple mechanisms may postpone imminent cell
death by removal of active inflammasome, and enhance the
secretion of IL-1β (Figure 1C). During prolonged exposure
to signal 2, the cell undergoes pyroptotic cell death, which is
associated with membrane damage and leakage of cytoplasm
contents. However, several studies suggested existence of
caspase-1-dependent cell death that resembles apoptosis that
may be activated concomitantly to pyroptosis or at later
stages (74–77). Indeed Gsdmd deletion causes a shift from
pyroptotic to apoptotic-like phenotype in mouse models (31).
Similarly to classical apoptosis, such process may be associated
with compartmentalization of cellular content and effective
formation of EV similar to apopotic bodies (Figure 1D). Current
knowledge about these “pyroptotic vesicles” is very limited,
however their release has been showed in our recent study
(17). Consequently, EV-mediated secretion may be a major
inflammasome-dependent secretory route of IL-1β, IL-18,
and other proteins important for coordination of immune
response. There are however several questions still seeking
answers. First—do all NLRP3 inflammasome activators enhance
secretion of EV? Currently only a handful of canonical and one
non-canonical NLRP3 stimulus have been directly shown to
induce EV secretion. It has also not been determined whether
EV secretion occurs via one preferred route, dependent possibly
on a particular signal, or alternatively involving exosomes,
shedding microvesicles and blebs to a similar extent. Second—it
is obvious that kinetics of EV release varies significantly and
may range from minutes (ATP) to hours (β-glucan) after
inflammasome activation (14, 15). In order to corroborate the
view of inflammasome-activated EV secretion, it is important
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to further investigate the patterns and kinetics of “weak” and
“strong” NLRP3 activators (36) in stimulating EV secretion.
Finally, it will be essential to dissect the signal transduction
pathways activated by different inflammasome stimuli on one
hand, and those downstream NLRP3 and caspases-4/5 on the
other, monitoring their roles in formulation, cargo selection and
secretion of EV. These investigations may in the future provide
novel explanations on inflammasome and EV biology improving
understanding of inflammatory diseases and revealing novel
therapeutic targets.
AUTHOR CONTRIBUTIONS
WC and SM designed and wrote the manuscript. TN critically
revised the manuscript.
FUNDING
This work was funded by the statutory funds of the Centre
of Molecular and Macromolecular Studies, Polish Academy of
Sciences.
REFERENCES
1. Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, et al.
Biological properties of extracellular vesicles and their physiological functions.
J Extracell Vesicles (2015) 4:27066. doi: 10.3402/jev.v4.27066
2. Nyman TA, Lorey MB, Cypryk W, Matikainen S. Mass spectrometry-
based proteomic exploration of the human immune system: focus on the
inflammasome, global protein secretion, and T cells. Expert Rev Proteomics
(2017) 14:395–407. doi: 10.1080/14789450.2017.1319768
3. Shi J, Zhao Y, Wang Y, Gao W, Ding J, Li P, et al. Inflammatory
caspases are innate immune receptors for intracellular LPS. Nature (2014)
514(7521):187–92. doi: 10.1038/nature13683
4. Hulsmans M, Holvoet P. MicroRNA-containing microvesicles regulating
inflammation in association with atherosclerotic disease. Cardiovasc Res.
(2013) 100:7–18. doi: 10.1093/cvr/cvt161
5. Perrotta I, Aquila S. The role of oxidative stress and autophagy
in atherosclerosis. Oxid Med Cell Longev. (2015) 2015:130315.
doi: 10.1155/2015/130315
6. Hafiane A, Daskalopoulou SS. Extracellular vesicles characteristics and
emerging roles in atherosclerotic cardiovascular disease. Metabolism (2018)
85:213–22. doi: 10.1016/j.metabol.2018.04.008
7. Ghidoni R, Paterlini A, Albertini V, Glionna M, Monti E, Schiaffonati L, et al.
Cystatin C is released in association with exosomes: a new tool of neuronal
communication which is unbalanced in Alzheimer’s disease. Neurobiol Aging
(2011) 32:1435–42. doi: 10.1016/j.neurobiolaging.2009.08.013
8. Gui Y, Liu H, Zhang L, Lv W, Hu X. Altered microRNA profiles in
cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
Oncotarget (2015) 6:37043–53. doi: 10.18632/oncotarget.6158
9. Yang TT, Liu CG, Gao SC, Zhang Y, Wang PC. The serum exosome
derived microRNA-135a,−193b, and−384 were potential alzheimer’s disease
biomarkers. Biomed Environ Sci. (2018) 31:87–96. doi: 10.3967/bes2018.011
10. Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D. High complement
levels in astrocyte-derived exosomes of Alzheimer disease.Ann Neurol. (2018)
83:544–52. doi: 10.1002/ana.25172
11. Withrow J, Murphy C, Liu Y, HunterM, Fulzele S, HamrickMW. Extracellular
vesicles in the pathogenesis of rheumatoid arthritis and osteoarthritis.
Arthritis Res Ther. (2016) 18:286. doi:10.1186/s13075-016-1178-8
12. van Hezel ME, Nieuwland R, Bruggen RV, Juffermans NP. The ability of
extracellular vesicles to induce a pro-inflammatory host response. Int J Mol
Sci. (2017) 18:E1285. doi: 10.3390/ijms18061285
13. Välimäki E, Miettinen JJ, Lietzén N, Matikainen S, Nyman TA. Monosodium
urate activates Src/Pyk2/PI3 kinase and cathepsin dependent unconventional
protein secretion from human primary macrophages. Mol Cell Proteomics
(2013) 12:749–63. doi: 10.1074/mcp.M112.024661
14. Cypryk W, Ohman T, Eskelinen EL, Matikainen S, Nyman TA. Quantitative
proteomics of extracellular vesicles released from human monocyte-derived
macrophages upon β-glucan stimulation. J Proteome Res. (2014) 13:2468–77.
doi: 10.1021/pr4012552
15. Välimäki E, Cypryk W, Virkanen J, Nurmi K, Turunen PM, Eklund
KK, et al. Calpain activity is essential for ATP-driven unconventional
vesicle-mediated protein secretion and inflammasome activation in human
macrophages. J Immunol. (2016) 197:3315–25. doi: 10.4049/jimmunol.15
01840
16. Cypryk W, Lorey M, Puustinen A, Nyman TA, Matikainen S. Proteomic
and bioinformatic characterization of extracellular vesicles released from
human macrophages upon influenza A virus infection. J Proteome Res. (2017)
16:217–27. doi: 10.1021/acs.jproteome.6b00596
17. Lorey MB, Rossi K, Eklund KK, Nyman TA, Matikainen S. Global
characterization of protein secretion from human macrophages following
non-canonical caspase-4/5 inflammasome activation. Mol Cell Proteomics
(2017) 16(4 suppl. 1):S187–99. doi: 10.1074/mcp.M116.064840
18. Singhto N, Kanlaya R, Nilnumkhum A, Thongboonkerd V. Roles of
macrophage exosomes in immune response to calcium oxalate monohydrate
crystals. Front Immunol. (2018) 9:316. doi: 10.3389/fimmu.2018.
00316
19. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G. The cytolytic
P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science
(1996) 272:735–8.
20. Mariathasan S, Weiss DS, Newton K, McBride J, O’Rourke K, Roose-Girma
M, et al. Cryopyrin activates the inflammasome in response to toxins and ATP.
Nature (2006) 440:228–32. doi: 10.1038/nature04515
21. de Torre-Minguela C, Barberà-Cremades M, Gómez AI, Martín-Sánchez F,
Pelegrín P. Macrophage activation and polarization modify P2X7 receptor
secretome influencing the inflammatory process. Sci Rep. (2016) 6:22586.
doi: 10.1038/srep22586
22. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric
acid crystals activate the NALP3 inflammasome. Nature (2006) 440:237–41.
doi: 10.1038/nature0451
23. Öhman T, Teirilä L, Lahesmaa-Korpinen AM, CyprykW, Veckman V, Saijo S,
et al. Dectin-1 pathway activates robust autophagy-dependent unconventional
protein secretion in human macrophages. J Immunol. (2014) 192:5952–62.
doi: 10.4049/jimmunol.1303213
24. Hornung V, Latz E. Critical functions of priming and lysosomal
damage for NLRP3 activation. Eur J Immunol. (2010) 40:620–3.
doi: 10.1002/eji.200940185
25. Zhang Y, Liu F, Yuan Y, Jin C, Chang C, Zhu Y, et al. Inflammasome-derived
exosomes activate NF-κB signaling in macrophages. J Proteome Res. (2017)
16:170–178. doi: 10.1021/acs.jproteome.6b00599
26. Kayagaki N, Warming S, Lamkanfi M, Vande Walle L, Louie S, Dong J, et al.
Non-canonical inflammasome activation targets caspase-11. Nature (2011)
479:117–21. doi: 10.1038/nature10558
27. Broz P, Ruby T, Belhocine K, Bouley DM, Kayagaki N, Dixit VM et al. Caspase-
11 increases susceptibility to Salmonella infection in the absence of caspase-1.
Nature (2012) 490:288–91. doi: 10.1038/nature11419
28. Meunier E, Dick MS, Dreier RF, Schürmann N, Kenzelmann Broz D,
Warming S, et al. Caspase-11 activation requires lysis of pathogen-
containing vacuoles by IFN-induced GTPases. Nature (2014) 509:366–70.
doi: 10.1038/nature13157
29. Schmid-Burgk JL, Gaidt MM, Schmidt T, Ebert TS, Bartok E, Hornung
V. Caspase-4 mediates non-canonical activation of the NLRP3
inflammasome in human myeloid cells. Eur J Immunol. (2015) 45:2911–7.
doi: 10.1002/eji.201545523
30. Kayagaki N, Stowe IB, Lee BL, O’Rourke K, Anderson K, Warming
S, et al. Caspase-11 cleaves gasdermin D for non-canonical
inflammasome signalling. Nature (2015) 526:666–71. doi: 10.1038/nature
15541
Frontiers in Immunology | www.frontiersin.org 6 September 2018 | Volume 9 | Article 2188
Cypryk et al. Inflammasome-Dependent Extracellular Vesicle Secretion
31. He WT, Wan H, Hu L, Chen P, Wang X, Huang Z, et al. Gasdermin D is
an executor of pyroptosis and required for interleukin-1β secretion. Cell Res.
(2015) 25:1285–98. doi: 10.1038/cr.2015.139
32. Man SM, Karki R, SasaiM, Place DE, Kesavardhana S, Temirov J, et al. IRGB10
liberates bacterial ligands for sensing by the AIM2 and caspase-11-NLRP3
inflammasomes. Cell (2016) 167:382–96.e17. doi: 10.1016/j.cell.2016.09.012
33. Liu X, Zhang Z, Ruan J, Pan Y, Magupalli VG, Wu H, et al. Inflammasome-
activated gasdermin D causes pyroptosis by forming membrane pores.Nature
(2016) 535:153–8. doi: 10.1038/nature18629
34. Mulvihill E, Sborgi L, Mari SA, Pfreundschuh M, Hiller S, Müller DJ.
Mechanism of membrane pore formation by human gasdermin-D. EMBO J
(2018) 37:e98321. doi: 10.15252/embj.201798321
35. Evavold CL, Ruan J, Tan Y, Xia S, Wu H, Kagan JC. The pore-
forming protein gasdermin D regulates interleukin-1 secretion from living
macrophages. Immunity (2018) 48:35–44.e6. doi: 10.1016/j.immuni.2017.
11.013
36. Kuriakose T, Kanneganti TD. Gasdermin D flashes an exit signal for IL-1.
Immunity (2018) 48:1–3. doi: 10.1016/j.immuni.2018.01.003
37. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D, Deretic V.
Autophagy-based unconventional secretory pathway for extracellular delivery
of IL-1β. EMBO J. (2011) 30:4701–11. doi: 10.1038/emboj.2011.398
38. Harris J, HartmanM, Roche C, Zeng SG, O’Shea A, Sharp FA, et al. Autophagy
controls IL-1beta secretion by targeting pro-IL-1beta for degradation. J Biol
Chem. (2011) 286:9587–97. doi: 10.1074/jbc.M110.202911
39. Iula L, Keitelman IA, Sabbione F, Fuentes F, Guzman M, Galletti JG, et al.
Autophagy mediates interleukin-1β secretion in human neutrophils. Front
Immunol. (2018) 9:269. doi: 10.3389/fimmu.2018.00269
40. Claude-Taupin A, Bissa B, Jia J, Gu Y, Deretic V. Role of autophagy in
IL-1β export and release from cells. Semin Cell Dev Biol. (2018).
doi: 10.1016/j.semcdb.2018.03.012. [Epub ahead of print].
41. Qu Y, Franchi L, Nunez G, Dubyak GR. Nonclassical IL-1 beta secretion
stimulated by P2X7 receptors is dependent on inflammasome activation and
correlated with exosome release in murine macrophages. J Immunol. (2007)
179:1913–25. doi: 10.4049/jimmunol.179.3.1913
42. Cullen SP, Kearney CJ, Clancy DM, Martin SJ. Diverse activators of the
NLRP3 inflammasome promote IL-1β secretion by triggering necrosis. Cell
Rep. (2015) 11:1535–48. doi: 10.1016/j.celrep.2015.05.003
43. Lopez-Castejon G, Brough D. Understanding the mechanism of
IL-1β secretion. Cytokine Growth Factor Rev. (2011) 22:189–95.
doi: 10.1016/j.cytogfr.2011.10.001
44. Brough D, Pelegrin P, Nickel W. An emerging case for membrane pore
formation as a commonmechanism for the unconventional secretion of FGF2
and IL-1β. J Cell Sci. (2017) 130:3197–3202. doi: 10.1242/jcs.204206
45. Shi J, Zhao Y, Wang K, Shi X, Wang Y, Huang H, et al. Cleavage of GSDMD
by inflammatory caspases determines pyroptotic cell death. Nature (2015)
526:660–5. doi: 10.1038/nature15514
46. Sitia R, Rubartelli A. The unconventional secretion of IL-1β: Handling a
dangerous weapon to optimize inflammatory responses. Semin Cell Dev Biol.
(2018). doi: 10.1016/j.semcdb.2018.03.011. [Epub ahead of print].
47. Pizzirani C, Ferrari D, Chiozzi P, Adinolfi E, Sandonà D, Savaglio
E, et al. Stimulation of P2 receptors causes release of IL-1beta-loaded
microvesicles from human dendritic cells. Blood (2007) 109:3856–64.
doi: 10.1182/blood-2005-06-031377
48. Gulinelli S, Salaro E, Vuerich M, Bozzato D, Pizzirani C, Bolognesi G,
et al. IL-18 associates to microvesicles shed from human macrophages by a
LPS/TLR-4 independent mechanism in response to P2X receptor stimulation.
Eur J Immunol. (2012) 42:3334–45. doi: 10.1002/eji.201142268
49. Yoon S, Kovalenko A, Bogdanov K, Wallach D. MLKL, the protein
that mediates necroptosis, also regulates endosomal trafficking
and extracellular vesicle generation. Immunity (2017) 47:51–65.e7.
doi: 10.1016/j.immuni.2017.06.001
50. Prada I, Furlan R, Matteoli M, Verderio C. Classical and unconventional
pathways of vesicular release in microglia. Glia (2013) 61:1003–17.
doi: 10.1002/glia.22497
51. Perregaux D, Gabel CA. Interleukin-1 beta maturation and release in response
to ATP and nigericin. Evidence that potassium depletion mediated by these
agents is a necessary and common feature of their activity. J Biol Chem. (1994)
269:15195–203.
52. Piccini A, Carta S, Tassi S, Lasiglié D, Fossati G, Rubartelli A. ATP is released
by monocytes stimulated with pathogen-sensing receptor ligands and induces
IL-1beta and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA.
(2008) 105:8067–72. doi: 10.1073/pnas.0709684105
53. Muñoz-Planillo R, Kuffa P, Martínez-Colón G, Smith BL, Rajendiran TM,
Núñez G. K? efflux is the common trigger of NLRP3 inflammasome activation
by bacterial toxins and particulate matter. Immunity (2013) 38:1142–53.
doi: 10.1016/j.immuni.2013.05.016
54. Harder J, Franchi L, Muñoz-Planillo R, Park JH, Reimer T, Núñez G.
Activation of the Nlrp3 inflammasome by Streptococcus pyogenes requires
streptolysin O and NF-kappa B activation but proceeds independently
of TLR signaling and P2X7 receptor. J Immunol. (2009) 183:5823–9.
doi: 10.4049/jimmunol.0900444
55. Murakami T, Ockinger J, Yu J, Byles V, McColl A, Hofer AM, et al. Critical role
for calciummobilization in activation of the NLRP3 inflammasome. Proc Natl
Acad Sci USA. (2012) 109:11282–7. doi: 10.1073/pnas.1117765109
56. Perregaux DG, Laliberte RE, Gabel CA. Human monocyte interleukin-1beta
posttranslational processing. Evidence of a volume-regulated response. J Biol
Chem. (1996) 271:29830–8.
57. Haller T, Dietl P, Deetjen P, Völkl H. The lysosomal compartment as
intracellular calcium store in MDCK cells: a possible involvement in InsP3-
mediated Ca2+ release. Cell Calcium (1996) 19:157–65.
58. Tissot J-D, Canellini G, Rubin O, Angelillo-Scherrer A, Delobel J, Prudent M
et al. Blood microvesicles: from proteomics to physiology. Transl Proteomics
(2013) 1:38–52. doi: 10.1016/j.trprot.2013.04.004
59. Kalra H, Drummen GP, Mathivanan S. Focus on extracellular vesicles:
introducing the next small big thing. Int J Mol Sci. (2016) 17:170.
doi: 10.3390/ijms17020170
60. Saido TC, Sorimachi H, Suzuki K. Calpain: new perspectives in molecular
diversity and physiological-pathological involvement. FASEB J. (1994)
8:814–22.
61. Weber H, Hühns S, Lüthen F, Jonas L. Calpain-mediated breakdown
of cytoskeletal proteins contributes to cholecystokinin-induced
damage of rat pancreatic acini. Int J Exp Pathol. (2009) 90:387–99.
doi: 10.1111/j.1365-2613.2009.00638.x
62. Crespin M, Vidal C, Picard F, Lacombe C, Fontenay M. Activation of PAK1/2
during the shedding of platelet microvesicles. Blood Coagul Fibrinol. (2009)
20:63–70. doi: 10.1097/MBC.0b013e32831bc310
63. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG,
et al. NLRP3 inflammasomes are required for atherogenesis and activated by
cholesterol crystals. Nature (2010) 464:1357–61. doi: 10.1038/nature08938
64. Rajamäki K, Lappalainen J, Oörni K, Välimäki E, Matikainen S, Kovanen
PT, et al. Cholesterol crystals activate the NLRP3 inflammasome in human
macrophages: a novel link between cholesterol metabolism and inflammation.
PLoS ONE (2010) 5:e11765. doi: 10.1371/journal.pone.0011765
65. Pazár B, Ea HK, Narayan S, Kolly L, Bagnoud N, Chobaz V, et al. Basic
calcium phosphate crystals induce monocyte/macrophage IL-1β secretion
through the NLRP3 inflammasome in vitro. J Immunol. (2011) 186:2495–502.
doi: 10.4049/jimmunol.1001284
66. Kankkunen P, Teirilä L, Rintahaka J, Alenius H, Wolff H,
Matikainen S. (1,3)-beta-glucans activate both dectin-1 and NLRP3
inflammasome in human macrophages. J Immunol. (2010) 184:6335–42.
doi: 10.4049/jimmunol.0903019
67. Rintahaka J, Lietzén N, Öhman T, Nyman TA, Matikainen S. Recognition of
cytoplasmic RNA results in cathepsin-dependent inflammasome activation
and apoptosis in human macrophages. J Immunol. (2011) 186:3085–92.
doi: 10.4049/jimmunol.1002051
68. Orlowski GM, Colbert JD, Sharma S, Bogyo M, Robertson SA, Rock KL.
Multiple cathepsins promote pro-IL-1β synthesis and NLRP3-mediated IL-1β
activation. J Immunol. (2015) 195:1685–97. doi: 10.4049/jimmunol.1500509
69. Keller M, Rüegg A, Werner S, Beer HD. Active caspase-1 is a
regulator of unconventional protein secretion. Cell (2008) 132:818–31.
doi: 10.1016/j.cell.2007.12.040
70. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M. The caspase-1
digestome identifies the glycolysis pathway as a target during infection and
septic shock. J Biol Chem. (2007) 282:36321–9. doi: 10.1074/jbc.M708182200
71. de Rivero Vaccari JP, Brand F III, Adamczak S, Lee SW, Perez-Barcena
J, Wang MY, et al. Exosome-mediated inflammasome signaling after
Frontiers in Immunology | www.frontiersin.org 7 September 2018 | Volume 9 | Article 2188
Cypryk et al. Inflammasome-Dependent Extracellular Vesicle Secretion
central nervous system injury. J Neurochem. (2016) 136(Suppl. 1):39–48.
doi: 10.1111/jnc.13036
72. Wang L, Fu H, Nanayakkara G, Li Y, Shao Y, Johnson C, et al.
Novel extracellular and nuclear caspase-1 and inflammasomes propagate
inflammation and regulate gene expression: a comprehensive database
mining study. J Hematol Oncol. (2016) 9:122. doi: 10.1186/s13045-016-
0351-5
73. Qu Y, Ramachandra L, Mohr S, Franchi L, Harding CV, Nunez G, et al. P2X7
receptor-stimulated secretion of MHC class II-containing exosomes requires
the ASC/NLRP3 inflammasome but is independent of caspase-1. J Immunol.
(2009) 182:5052–62. doi: 10.4049/jimmunol.0802968
74. Pierini R, Juruj C, Perret M, Jones CL, Mangeot P, Weiss DS, et al.
AIM2/ASC triggers caspase-8-dependent apoptosis in Francisella-infected
caspase-1-deficient macrophages. Cell Death Differ. (2012) 19:1709–21.
doi: 10.1038/cdd.2012.51
75. Sagulenko V, Thygesen SJ, Sester DP, Idris A, Cridland JA, Vajjhala PR,
et al. AIM2 and NLRP3 inflammasomes activate both apoptotic and
pyroptotic death pathways via ASC. Cell Death Differ. (2013) 20:1149–60.
doi: 10.1038/cdd.2013.37
76. Aachoui Y, Sagulenko V, Miao EA, Stacey KJ. Inflammasome-mediated
pyroptotic and apoptotic cell death, and defense against infection. Curr Opin
Microbiol. (2013) 16:319–26. doi: 10.1016/j.mib.2013.04.004
77. Lee BL, Mirrashidi KM, Stowe IB, Kummerfeld SK, Watanabe C, Haley
B, et al. ASC- and caspase-8-dependent apoptotic pathway diverges
from the NLRC4 inflammasome in macrophages. Sci Rep. (2018) 8:3788.
doi: 10.1038/s41598-018-21998-3
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2018 Cypryk, Nyman and Matikainen. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the
original author(s) and the copyright owner(s) are credited and that the original
publication in this journal is cited, in accordance with accepted academic practice.
No use, distribution or reproduction is permitted which does not comply with these
terms.
Frontiers in Immunology | www.frontiersin.org 8 September 2018 | Volume 9 | Article 2188
